已收盘 10-31 16:00:00 美东时间
-0.050
-0.07%
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
10-31 10:25
Wells Fargo analyst Larry Biegelsen maintains GE HealthCare Techs (NASDAQ:GEHC) with a Overweight and lowers the price target from $89 to $87.
10-30 22:36
GE HealthCare Q3 earnings beat estimates as sales rise 6% and orders grow 6% organically, prompting a raised full-year profit outlook despite tariff costs.
10-29 23:42
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
华盛资讯10月29日讯,GE HealthCare Technologies Inc.公司今日公布2025财年Q3业绩,公司Q3营收51.43亿美元,同比增长5.8%,股权持有人应占溢利4.46亿美元,同比下滑5.1%。
10-29 18:57
GE HealthCare Techs (NASDAQ:GEHC) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $1.05 by 2 percent. This is a 6.14 percent decrease over earnings of $1.14 per share from the
10-29 18:20
GE HealthCare Techs (NASDAQ:GEHC) will release its quarterly earnings report on...
10-29 00:03
GE HealthCare (NASDAQ:GEHC) today announced collaborations with two leading U.S. health systems—The Queen's Health Systems in Honolulu, HI and Duke Health in Durham, NC—to help advance the development of GE HealthCare's
10-21 00:23